Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia.
Gene Name: | Fanconi anemia, complementation group A |
Synonyms: | FANCA, FA1, FACA, FA-H, Fanconi anemia group A protein, Fanconi anemia, type 1, FA, Protein FACA, FAA, FANCH |
Target Sequences: | NM_000135 NP_000126.2 O15360 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.